OPUM Technologies, a medical technology company focused on transforming knee health, performance, and recovery, announced significant growth of its Digital Knee platform, an AI-driven wearable and analytics system delivering continuous, clinical-grade biomechanical insights. The company also named Regiment Securities LLC as its exclusive investment bank to guide strategic planning and capital initiatives. The Digital Knee platform integrates patented sensors, motion analytics, and artificial intelligence to track real-world knee biomechanics continuously, offering data far beyond traditional assessments or subjective observation.
Health Technology Insights: Allink Biotherapeutics Secures $47Million Series A Extension
Its Dynamic Goniometry feature measures knee motion during real activity, providing clinicians, trainers, and sports performance teams with previously unavailable insights. Designed for both clinical and elite athletic settings, the Digital Knee works with braces and soft sleeves while connecting to a patient-facing app and clinician dashboard.
Health Technology Insights: Cosette Pharma Launches First Generic CIPRO HC with CGT Exclusivity
This approach gives a comprehensive view of knee health, helping prevent injuries, optimize rehabilitation, guide return-to-play decisions, and preserve joint function over time. OPUM’s technology supports reimbursable remote therapeutic monitoring workflows, aligning AI capabilities with scalable care delivery and positioning the company at the intersection of digital health, orthopedics, and sports science. David Smith, Chief Executive Officer of OPUM Technologies, stated, “Our goal is to change how knee health is understood and managed across orthopedics, rehabilitation, and sports performance. The Digital Knee provides continuous, objective data that was previously inaccessible.
Bringing Regiment on board allows us to explore strategic opportunities and leverage their expertise as we grow responsibly.” Regiment will provide guidance on capital strategy and long-term growth, enhancing OPUM’s credibility as it expands into healthcare and performance markets. Dean Delisle, Chief Revenue Officer at Regiment, said, “OPUM has created a unique AI and sensor platform capable of transforming musculoskeletal care. We are excited to support them as they scale and broaden their impact in both clinical and athletic environments.”
Health Technology Insights: Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
